Postantibiotic effects of antituberculosis agents alone and in combination

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3631-3634

  Chan, C Y ^a   Au Yeang, C ^a   Yew, W W ^a   Hui, M ^a   Cheng, A F B ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIMYCOBACTERIAL AGENT; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; DRUG INTERACTIONS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NEPHELOMETRY AND TURBIDIMETRY;

EID: 0035191461     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3631-3634.2001     Document Type: Article

References (26)

1. Postantibiotic suppression of bacterial growth
2. A 62-dose, 6-month therapy for pulmonary and extra-pulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen
3. Killing and regrowth of bacteria in vitro: A review
4. Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis
5. In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens
6. Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis
7. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis
8. Whither short course chemotherapy?
9. Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method
10. Postantibiotic effect in vitro
11. The specific inhibition of the DNA-directed RNA synthesis by rifamycin
12. Antimycobacterial agents: In vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids
13. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods
14. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time
15. Laboratory aspects of intermittent drug therapy
16. Using therapeutic drug monitoring to dose the antimycobacterial drugs
17. Five year follow up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary, tuberculosis
18. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum
19. Effects of colonial morphology and Tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis
20. Postantibiotic effects
21. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
22. Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria
23. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens
24. In-vitro activity of quinolones and macrolides against mycobacteria
25. 2 generation (Bactec) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex